Beta-lactamase targeted enzyme activatable photosensitizers for antimicrobial PDT

Xiang Zheng; Sarika Verma; Ulysses W. Sallum; Tayyaba Hasan

doi:10.1117/12.824500

13 July 2009 Beta-lactamase targeted enzyme activatable photosensitizers for antimicrobial PDT

Xiang Zheng, Sarika Verma, Ulysses W. Sallum, Tayyaba Hasan

Proceedings Volume 7380, Photodynamic Therapy: Back to the Future; 73802H (2009) https://doi.org/10.1117/12.824500
Event: 12th World Congress of the International Photodynamic Association, 2009, Seattle, Washington, United States

Abstract

Photodynamic therapy (PDT) as a treatment modality for infectious disease has shown promise. However, most of the antimicrobial photosensitizers (PS) non-preferentially accumulate in both bacteria and host tissues, causing host tissue phototoxicity during treatment. We have developed a new antimicrobial PDT strategy which exploits beta-lactam resistance mechanism, one of the major drug-resistance bacteria evolved, to achieve enhanced target specificity with limited host damage. Our strategy comprises a prodrug construct with a PS and a quencher linked by beta-lactam ring, resulting in a diminished phototoxicity. This construct, beta-lactamase enzyme-activated-photosensitizer (beta-LEAP), can only be activated in the presence of both light and bacteria, and remains inactive elsewhere such as mammalian tissue. Beta-LEAP construct had shown specific cleavage by purified beta-lactamase and by beta-lactamase over-expressing methicillin resistant Staphylococcus aureus (MRSA). Specific photodynamic toxicity was observed towards MRSA, while dark and light toxicity were equivalent to reference strains. The prodrug design, synthesis and photophysical properties will be discussed.

Citation Download Citation

Xiang Zheng, Sarika Verma, Ulysses W. Sallum, and Tayyaba Hasan "Beta-lactamase targeted enzyme activatable photosensitizers for antimicrobial PDT", Proc. SPIE 7380, Photodynamic Therapy: Back to the Future, 73802H (13 July 2009); https://doi.org/10.1117/12.824500

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available